Serum amyloid A and misfolded transthyretin may be the two predictable biomarkers to relapsed/ refractory diffuse

Hu Liu1, Shu-Ying Liu1, Qiao-Hua Zhang1

  • 1Department of Lymphoma, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, 030032, China; Department of Lymphoma, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

Abstract

No abstract available in PubMed .